Carcinoembryonic antigen assayed by column chromatography on polyacrylamide gel

Area of Science:

• Clinical Chemistry
• Biochemical Assays
• Analytical Toxicology

Background:

• Carcinoembryonic antigen (CEA) is a tumor marker frequently monitored in clinical practice.
• Conventional methods for CEA assay often involve time-consuming dialysis steps.
• There is a need for more efficient and accessible diagnostic tools for CEA quantification.

Purpose of the Study:

• To evaluate a commercially available polyacrylamide column for its utility in CEA assays.
• To assess the performance characteristics of this novel assay method compared to conventional techniques.

Main Methods:

• Utilized a polyacrylamide column (Clinetics Corp.) for the quantitative determination of CEA.
• Assayed 50 samples in duplicate, processing up to 50 samples within a 5-hour timeframe.
• Compared results with a conventional dialysis method, assessing correlation and agreement.

Main Results:

• The polyacrylamide column method demonstrated high precision, with within-day CVs of 6.55% and 2.92%, and between-day CVs of 10.0% and 8.91%.
• Assay results were generally lower by 1.0 microgram/L (range 0.5-2.0) compared to the conventional dialysis method, with a strong correlation (r = 0.9876).
• Sensitivity was found to be approximately 0.5 microgram/L, and analytical recovery ranged from 73% to 80%.

Conclusions:

• The evaluated polyacrylamide column provides a rapid and efficient alternative for CEA assay, eliminating the need for dialysis.
• The method offers reliable precision and accuracy, making it suitable for routine clinical diagnostics.
• This technique enhances throughput and potentially reduces turnaround time for CEA testing.